The DOI matches its Crossref record; 84 of the 85 references it cites were found in a registry or an index.
Tuberculosis Diagnostics and Biomarkers: Needs, Challenges, Recent Advances, and Opportunities
Open accessAbstract
Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary tuberculosis in a timely fashion, allowing continued Mycobacterium tuberculosis transmission within communities. Currently recommended gold-standard diagnostic tests for tuberculosis are laboratory based, and multiple investigations may be necessary over a period of weeks or months before a diagnosis is made. Several new diagnostic tests have recently become available for detecting active tuberculosis disease, screening for latent M. tuberculosis infection, and identifying drug-resistant strains of M. tuberculosis. However, progress toward a robust point-of-care test has been limited, and novel biomarker discovery remains challenging. In the absence of effective prevention strategies, high rates of early case detection and subsequent cure are required for global tuberculosis control. Early case detection is dependent on test accuracy, accessibility, cost, and complexity, but also depends on the political will and funder investment to deliver optimal, sustainable care to those worst affected by the tuberculosis and human immunodeficiency virus epidemics. This review highlights unanswered questions, challenges, recent advances, unresolved operational and technical issues, needs, and opportunities related to tuberculosis diagnostics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Second, availability issues, such as geographical constraints, resource shortages, or long waiting times, can cause significant diagnostic errors even when specific tests exist [189,190].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [189]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dye, C., Scheele, S., >Dolin, P., Pathania, V. S., Raviglione, M. C., & for the WHO Global Surveillance and Monitoring Project (1999) · JAMA · doi:10.1001/jama.282.7.677 · Cited by 2,955
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309
(2012) · Choice Reviews Online · doi:10.5860/choice.49-6620 · Cited by 1,284
A systematic review of delay in the diagnosis and treatment of tuberculosis
Storla, D. G., Yimer, S. A., & Bjune, G. A. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-15 · Cited by 1,023
Boehme, C. C., Nicol, M. P., Nabeta, P., Michael, J. S., Gotuzzo, E., Tahirli, R., Gler, M. T., Blakemore, R., Worodria, W. O., Gray, C. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60438-8 · Cited by 1,007
Self-citationHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 804
Self-citationNewsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 636
Steingart, K. R., Ng, V., Henry, M., Hopewell, P. C., Ramsay, A., Cunningham, J. A., Urbanczik, R., Perkins, M. D., Aziz, M. A., & Pai, M. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70602-8 · Cited by 580
Diel, R., Goletti, D., Ferrara, G., Bothamley, G. H., Cirillo, D. M., Kampmann, B., Lange, C. G., Losi, M., Markova, R., Migliori, G. B., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00115110 · Cited by 542
Self-citation
Research works printed but not linked: 10
- World Health Organization, 2011, WHO report. Global tuberculosis control
- World Health Organization, 2010, Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response
- World Health Organization, 2011, Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement
- European Centre for Disease Prevention and Control, 2011, Use of interferon-gamma release assays in support of tuberculosis diagnosis
- World Health Organization, 2010, Use of interferon-γ release assays (IGRAs) in TB control in low and middle-income settings
- World Health Organization, 2011, Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational “How-to”; practical considerations
- 2011, FIND. Performance of Xpert MTB/RIF version G4 assay. Geneva: Foundation for Innovative New Diagnostics
- World Health Organization, 2008, New laboratory diagnostic tools for tuberculosis control
- World Health Organization, 2009, Report of the 9th meeting: WHO strategic and technical advisory group for tuberculosis
- Treatment Action Group, 2009, 2009 report on tuberculosis research funding Trends, 2005–2008
Cited by
Sorted by citations
Clark, A. E., Kaleta, E. J., Arora, A., & Wolk, D. M. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00072-12 · Cited by 949
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A. I., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 921
Self-citationZumla, A. I., Raviglione, M. C., Hafner, R., & von Reyn, C. F. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1200894 · Cited by 699
Self-citationLawn, S. D., Mwaba, P., Bates, M., Piatek, A. S., Alexander, H. L., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L. S., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 459
Self-citationProspects for Tuberculosis Elimination
Dye, C., Glaziou, P., Floyd, K., & Raviglione, M. C. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031912-114431 · Cited by 405
Metadata
- Authors
- McNerney, R., Maeurer, M., Abubakar, I., Marais, B., Mchugh, T. D., Ford, N., Weyer, K., Lawn, S., Grobusch, M. P., Memish, Z., Squire, S. B., Pantaleo, G., Chakaya, J., Casenghi, M., Migliori, G.-B., Mwaba, P., Zijenah, L., Hoelscher, M., Cox, H., Swaminathan, S., Kim, P. S., Schito, M., Harari, A., Bates, M., Schwank, S., O’Grady, J., Pletschette, M., Ditui, L., Atun, R., & Zumla, A.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Karolinska Institutet (SE)
- University of East Anglia (GB)
- The University of Sydney (AU)
- University College London (GB)
- Médecins Sans Frontières (ZA)
- World Health Organization (CH)
- University of Cape Town (ZA)
- Amsterdam UMC Location University of Amsterdam (NL)
- Alfaisal University (SA)
- Liverpool School of Tropical Medicine (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- Kenya Medical Research Institute (KE)
- Ministry of Health (ZM)
- University of Zimbabwe (ZW)
- National Institute of Research in Tuberculosis (IN)
- National Institutes of Health (US)
- Henry M. Jackson Foundation (US)
- University of Zambia (ZM)
- European Commission (BE)
- Global Fund to Fight AIDS, Tuberculosis and Malaria (CH)
- Corresponding author
- McNerney, Ruth
- ORCID
- McNerney, Ruth
- Maeurer, Markus
- Abubakar, Ibrahim
- Marais, Ben
- Mchugh, Timothy D.
- Ford, Nathan
- Grobusch, Martin P.
- Memish, Ziad
- Squire, S. Bertel
- Pantaleo, Giuseppe
- Chakaya, Jeremiah
- Casenghi, Martina
- Mwaba, Peter
- Zijenah, Lynn
- Cox, Helen
- Swaminathan, Soumya
- Kim, Peter S.
- Schito, Marco
- Harari, Alexandre
- Bates, Matthew
- O’Grady, Justin
- Atun, Rifat
- Zumla, Alimuddin
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-15
- Volume
- 205
- Issue
- suppl_2
- Pages
- S147-S158
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2145481449
- Cited by
- 191
- References
- 85
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 9 · 2020: 5 · 2019: 12 · 2018: 7 · 2017: 13 · 2016: 16 · 2015: 23 · 2014: 21 · 2013: 36 · 2012: 12
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- Locations
- The Journal of Infectious Diseases (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) (acceptedVersion)
- reroDoc Digital Library (submittedVersion)
- IRIS (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- LSTM Online Archive (Liverpool School of Tropical Medicine) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Medecins Sans Frontieres Field Research (Medecins Sans Frontieres) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UEA Digital Repository (University of East Anglia) (submittedVersion)
- Funders
- University College London
- UBS Optimus Foundation
- University College London Hospitals NHS Foundation Trust
- Medical Research Council
- European and Developing Countries Clinical Trials Partnership
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Keywords
- tuberculosis diagnosis, Mycobacterium tuberculosis, biomarkers, point-of-care testing, latent tuberculosis infection, drug-resistant tuberculosis, early case detection, tuberculosis control
- MeSH terms
- Antitubercular Agents, Bacteriological Techniques, Humans, Tuberculosis, Biomarkers, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
